Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-11T11:44:00.511Z Has data issue: false hasContentIssue false
  • English
  • Français

Alan Williams (1927–2005) and his contribution to health technology assessment

Published online by Cambridge University Press:  28 March 2006

Michael Drummond
Michael Drummond
Affiliation:
York, December 2005
Get access Rights & Permissions [Opens in a new window]

Extract

We should be careful when making claims that a given individual had a major impact on a given field. After all, much research is undertaken in teams and good ideas are quickly transferred and developed. There are, however, several reasons to suggest that Alan Williams made a major impact and that the field may have developed differently had he never become a health economist. I give five reasons below.

Type
IN MEMORIAM
Information
International Journal of Technology Assessment in Health Care , Volume 22 , Issue 2 , April 2006 , pp. 271 - 272
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Williams A. Cost-benefit analysis: Bastard science and/or insidious poison in the body politik? In: Wolfe JN, ed. 1973. Cost-benefit and cost effectiveness analysis. London: Allen and Unwin;
Williams A. 1974 The cost-benefit approach. Br Med Bull. 30: 252– 256.Google Scholar
The EuroQoL Group. 1990 EuroQoL—a new facility for the measurement of health-related quality of life. Health Policy. 16: 199– 208.
Williams A. 1997 Intergenerational equity: An exploration of the ‘fair innings’ argument. Health Econ. 6: 117– 132.Google Scholar